tiprankstipranks
Nova Mentis Life Science (NMLSF)
OTHER OTC:NMLSF

Nova Mentis Life Science (NMLSF) Financial Statements

17 Followers

Nova Mentis Life Science Financial Overview

Nova Mentis Life Science's market cap is currently ―. The company's EPS TTM is $-0.004; its P/E ratio is -2.38; Nova Mentis Life Science is scheduled to report earnings on August 28, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -144.38KC$ -209.56KC$ -184.06KC$ -302.79KC$ -528.00K
EBITDAC$ -143.80KC$ -210.29KC$ -181.86KC$ -302.06KC$ -527.27K
Net Income Common StockholdersC$ -144.38KC$ -209.56KC$ -184.06KC$ -302.79KC$ -528.00K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 21.82KC$ 8.09KC$ 24.44KC$ 17.44KC$ 113.94K
Total AssetsC$ 40.10KC$ 31.06KC$ 53.89KC$ 61.48KC$ 229.27K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -21.82KC$ -8.09KC$ -24.44KC$ -17.44KC$ -113.94K
Total LiabilitiesC$ 995.08KC$ 841.66KC$ 654.93KC$ 478.46KC$ 343.45K
Stockholders EquityC$ -954.98KC$ -810.60KC$ -601.04KC$ -416.98KC$ -114.19K
Cash Flow-
Free Cash FlowC$ -46.27KC$ 251.82KC$ -261.18KC$ -96.50KC$ -171.68K
Operating Cash FlowC$ -46.27KC$ 251.82KC$ -261.18KC$ -96.50KC$ -171.68K
Investing Cash Flow-----
Financing Cash FlowC$ 60.00KC$ -19.10KC$ 19.10K-C$ 19.10K
Currency in CAD

Nova Mentis Life Science Earnings and Revenue History

Nova Mentis Life Science Debt to Assets

Nova Mentis Life Science Cash Flow

Nova Mentis Life Science Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis